ERBB2 and familial pancreatic carcinoma: To assess the mechanisms underlying the role of HER3 in pancreatic cancer response to pertuzumab, HER2/HER3 expression, phosphorylation and downstream signaling were studied in NRG1β1-stimulated BxPC-3 cells after pertuzumab addition (Figure 5A).